Neurogenic inflammation and its role in migraine

R Ramachandran - Seminars in immunopathology, 2018 - Springer
The etiology of migraine pain involves sensitized meningeal afferents that densely innervate
the dural vasculature. These afferents, with their cell bodies located in the trigeminal …

A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features

LM Juliano, RR Griffiths - Psychopharmacology, 2004 - Springer
Rationale Although reports of caffeine withdrawal in the medical literature date back more
than 170 years, the most rigorous experimental investigations of the phenomenon have …

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b …

ME Bigal, L Edvinsson, AM Rapoport… - The Lancet …, 2015 - thelancet.com
Background Benefits of calcitonin-gene related peptide (CGRP) inhibition have not been
established in chronic migraine. Here we assess the safety, tolerability, and efficacy of two …

[HTML][HTML] Depression and risk of transformation of episodic to chronic migraine

S Ashina, D Serrano, RB Lipton, M Maizels… - The journal of headache …, 2012 - Springer
The aim of this study was to assess the role of depression as a predictor of new onset of
chronic migraine (CM) among persons with episodic migraine (EM). The American Migraine …

Tension-type headache

S Ashina, DD Mitsikostas, MJ Lee, N Yamani… - Nature Reviews …, 2021 - nature.com
Tension-type headache (TTH) is the most prevalent neurological disorder worldwide and is
characterized by recurrent headaches of mild to moderate intensity, bilateral location …

Current practice and future directions in the prevention and acute management of migraine

PJ Goadsby, T Sprenger - The Lancet Neurology, 2010 - thelancet.com
Migraine is a common and disabling brain disorder with a strong inherited component.
Because patients with migraine have severe and disabling attacks usually of headache with …

Transformed migraine and medication overuse in a tertiary headache centre—clinical characteristics and treatment outcomes

ME Bigal, AM Rapoport, FD Sheftell, SJ Tepper… - …, 2004 - journals.sagepub.com
Studies suggest that a substantial proportion of headache sufferers presenting to headache
clinics may overuse acute medications. In some cases, overuse may be responsible for the …

Botulinum Toxin Type A (BOTOX®) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial

NT Mathew, BM Frishberg, M Gawel… - … : The Journal of …, 2005 - Wiley Online Library
Objective.—The objective of this study was to evaluate the safety and efficacy of botulinum
toxin type A (BoNT‐A; BOTOX®, Allergan, Inc.) for the prophylactic treatment of chronic daily …

Understanding psychological stress, its biological processes, and impact on primary headache

JM Nash, RW Thebarge - Headache: The journal of head and …, 2006 - Wiley Online Library
Psychological stress is generally acknowledged to be a central contributor to primary
headache. Stress results from any challenge or threat, either real or perceived, to normal …

Diet and headache: part 1

VT Martin, B Vij - Headache: The Journal of Head and Face …, 2016 - Wiley Online Library
Background The role of diet in the management of the headache patient is a controversial
topic in the headache field. Objectives To review the evidence supporting the hypothesis …